KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Apr 22, 2019 $54.74 $55.76 $53.36 $53.97 728 982
Apr 18, 2019 $56.35 $56.99 $52.55 $54.85 1 259 063
Apr 17, 2019 $58.78 $58.78 $55.51 $56.59 709 413
Apr 16, 2019 $57.97 $59.09 $57.48 $58.33 605 015
Apr 15, 2019 $58.91 $59.19 $56.77 $57.44 500 422
Apr 12, 2019 $59.81 $59.95 $58.07 $59.02 577 831
Apr 11, 2019 $59.06 $59.53 $58.51 $59.08 425 251
Apr 10, 2019 $57.97 $59.07 $57.63 $59.05 501 161
Apr 09, 2019 $58.44 $59.40 $57.33 $57.56 508 678
Apr 08, 2019 $58.71 $58.88 $57.31 $58.51 461 137
Apr 05, 2019 $57.33 $59.72 $57.07 $59.01 649 318
Apr 04, 2019 $57.59 $58.39 $56.50 $57.24 675 123
Apr 03, 2019 $54.46 $57.92 $54.32 $57.76 937 765
Apr 02, 2019 $52.87 $54.20 $52.87 $54.05 361 026
Apr 01, 2019 $54.11 $54.19 $52.33 $52.90 617 306
Mar 29, 2019 $52.60 $53.83 $52.17 $52.93 675 565
Mar 28, 2019 $50.48 $52.25 $50.00 $52.00 487 853
Mar 27, 2019 $52.29 $52.78 $49.85 $50.47 818 533
Mar 26, 2019 $51.45 $52.47 $50.49 $52.44 376 226
Mar 25, 2019 $49.45 $51.07 $48.56 $50.89 628 443
Mar 22, 2019 $52.27 $52.35 $49.28 $49.51 630 236
Mar 21, 2019 $50.86 $52.59 $50.40 $52.51 412 000
Mar 20, 2019 $52.02 $52.22 $50.21 $51.15 482 079
Mar 19, 2019 $53.07 $53.07 $51.61 $51.96 488 599
Mar 18, 2019 $52.74 $54.09 $52.10 $52.89 798 528
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT